Simulations Plus, Inc. entered into Agreement and Plan of Merger with SP Evolution HoldCo II, LLC and SP Evolution BidCo II, LLC valued at $18.50 in cash (effective 2026-06-15).
“On June 15, 2026, Simulations Plus, Inc., a California corporation (the " Company "), entered into an Agreement and Plan of Merger (the " Merger Agreement ") by and among the Company, SP Evolution HoldCo II, LLC, a Delaware limited liability company and an affiliate of Altaris, LLC (" Parent ") and SP Evolution BidCo II, LLC, a Delaware limited liability company and a wholly owned subsidiary of Parent (" Merger Sub "), pursuant to which Merger Sub will merge with and into the Company (the " Merger "), with the Company surviving as a wholly owned subsidiary of Parent (the " Surviving Corporation ").”
Earnings Releases
Simulations Plus, Inc. reported second quarter fiscal 2026, ended February 28, 2026 results: revenue $24.3 million, net income $4.5 million, EPS $0.22. Guidance lowered.
“for its second quarter fiscal 2026, ended February 28, 2026. Second Quarter 2026 Financial Highlights (as compared to second quarter 2025) • Total revenue increased 8% to $24.3 million • Software revenue increased 9% to $14.6 million, representing 60% of total revenue • Services revenue increased 8% to $9.7 million, representing 40% of total revenue • Gross”
Auditor Changes
Simulations Plus, Inc. engaged Rose, Snyder & Jacobs LLC as its auditor.
“On July 9, 2025, the Audit Committee approved the selection and appointment of Rose, Snyder & Jacobs LLC (“RSJ”) to audit the Company’s consolidated financial statements for the fiscal year ending August 31, 2025, including the reviews of interim periods therein.”
Auditor Changes
Simulations Plus, Inc. dismissed Grant Thornton LLP as its auditor.
“On July 9, 2025, the Audit Committee of the Board of Directors (the “Audit Committee”) of Simulations Plus, Inc. (the “Company”) approved the dismissal of Grant Thornton LLP (“Grant Thornton”) as the Company’s independent public accounting firm.”
Restructurings & Charges
Simulations Plus, Inc. announced a restructuring with charges of approximately $0.7 million (approximately 23 employees).
“The reduction in workforce will decrease overall headcount by approximately 23 employees, which represents approximately 10% of full-time employees as of the Effective Date. The Company estimates that it will incur approximately $0.7 million in charges in connection with the restructuring, consisting of severance payments, employee benefits, and related costs”
Steven Chang changed role as Global Head of Strategic Alliances at Simulations Plus, Inc..
“Steven Chang , currently Business Unit President, Quantitative Systems Pharmacology Solutions, assumes the new role of Global Head of Strategic Alliances.”
Erik Guffrey changed role as Co-Chief Product and Technology Officer at Simulations Plus, Inc..
“Erik Guffrey , currently Chief Technology Officer, Adaptive Learning & Insights and Medical Communications Products, assumes the new role of Co-Chief Product and Technology Officer.”
Dr. Jonathan Chauvin changed role as Co-Chief Product and Technology Officer at Simulations Plus, Inc..
“Dr. Jonathan Chauvin , currently Business Unit Co-President, Clinical Pharmacology & Pharmacometric Solutions, assumes the new role of Co-Chief Product and Technology Officer.”
Jill Fiedler-Kelly changed role as Interim President, Services Solutions at Simulations Plus, Inc..
“Jill Fiedler-Kelly , currently Business Unit Co-President, Clinical Pharmacology & Pharmacometric Solutions, assumes the new role of Interim President, Services Solutions.”
Josh Fohey changed role as Chief Operating Officer at Simulations Plus, Inc..
“Josh Fohey , currently Senior Vice President, Operations, assumes the new role of Chief Operating Officer.”
Will Frederick changed role as Executive Vice President and Chief Financial Officer at Simulations Plus, Inc..
“Will Frederick , currently Chief Financial Officer and Chief Operating Officer, assumes the new role of Executive Vice President and Chief Financial Officer.”
Daniel Szot departed as Chief Revenue Officer at Simulations Plus, Inc..
“On the Effective Date, the Company and Daniel Szot, the Company’s Chief Revenue Officer, mutually agreed to Mr. Szot’s separation from the Company, to take effect at the end of the third fiscal quarter which allows for smooth transition as Mr. Szot seeks to pursue other opportunities.”
John DiBella was appointed as Chief Revenue Officer at Simulations Plus, Inc..
“On May 30, 2025 (the “Effective Date”), the Board of Directors (the “Board”) of Simulations Plus, Inc. (the “Company”) appointed John DiBella as Chief Revenue Officer of the Company, effective immediately.”
Auditor Changes
Simulations Plus, Inc. engaged Grant Thornton LLP as its auditor.
“the Audit Committee approved the selection and appointment of Grant Thornton LLP (“Grant Thornton”) to audit the Company’s consolidated financial statements for the fiscal year ending August 31, 2025, effective immediately.”
Auditor Changes
Simulations Plus, Inc. dismissed Rose, Snyder & Jacobs LLC as its auditor.
“The Audit Committee approved the dismissal of Rose, Snyder & Jacobs LLC (“RSJ”) as the Company’s independent registered public accounting firm and dismissed RSJ on April 15, 2025.”
Brett Howell departed as President, Quantitative Systems Pharmacology at Simulations Plus, Inc..
“Effective August 30, 2024, Dr. Brett Howell, Ph.D., has departed the Company.”
Michael Raymer was appointed as Business Unit President at Simulations Plus, Inc..
“on June 11, 2024, Michael Raymer, the chief executive officer of Pro-ficiency pre-Acquisition, was appointed as Business Unit President of the Company”
Earnings Releases
Simulations Plus, Inc. reported Full Year Fiscal 2024 results: revenue $66M - $69M, EPS $0.66 - $0.68. Guidance reaffirmed.
Simulations Plus, Inc. reported Second Quarter Fiscal 2024 ended February 29, 2024 results: revenue $18.3 million, net income $4.0 million, EPS $0.20.
“Second Quarter 2024 Financial Highlights (compared to second quarter 2023) • Total revenue increased 16% to $18.3 million • Software revenue increased 11% to $11.6 million, representing 63% of total revenue • Services revenue increased 27% to $6.7 million, representing 37% of total revenue • Gross profit increased to $13.2 million; gross margin was 72% • Adjusted EBITDA of $7.1 million, representing 39% of total revenue • Net income of $4.0 million and diluted earnings per share (EPS) of $0.20 versus net income of $4.2 million and diluted EPS of $0.20”
Shareholder Votes
Simulations Plus, Inc. shareholders approved To approve an amendment to the 2021 Plan to increase the number of shares authorized for issuance at the 2024-02-08 meeting.
“3. Proposal No. 3: To approve an amendment to the 2021 Plan to increase the number of shares authorized for issuance thereunder from 1,550,000 shares to 2,500,000 shares of common stock of the Company. This proposal was approved based upon the following votes: 1 Votes For Votes Against Votes Abstaining 12,504,641 913,457 31,050”
Shareholder Votes
Simulations Plus, Inc. shareholders approved To ratify the selection of Rose, Snyder & Jacobs LLP as the independent registered public accounting firm at the 2024-02-08 meeting.
“2. Proposal No. 2: To ratify the selection of Rose, Snyder & Jacobs LLP as the independent registered public accounting firm for the Company for the fiscal year ending August 31, 2024. This proposal was approved based upon the following votes: Votes For Votes Against Votes Abstaining 14,691,828 88,690 6,058”
Shareholder Votes
Simulations Plus, Inc. shareholders approved Election of five directors at the 2024-02-08 meeting.
“1. Proposal No. 1: To elect five individuals to serve on the Company's Board until the next Annual Meeting of Shareholders of the Company or until their successors are duly elected and qualified, subject to prior death, resignation, or removal. The votes were cast for this matter as follows: Nominees Votes For Votes Withheld Broker Non-votes Walter Woltosz 13,261,269 187,879 1,337,428 Dr. John K. Paglia 13,233,814 215,334 1,337,428 Sharlene Evans 13,301,624 147,524 1,337,428 Dr. Daniel Weiner 13,223,857 225,291 1,337,428 Lisa LaVange 13,225,460 223,688 1,337,428”
Earnings Releases
Simulations Plus, Inc. reported first quarter fiscal 2024, ended November 30, 2023 results: revenue $14.5 million, net income $1.9 million, EPS $0.10. Guidance reaffirmed.
“Simulations Plus Reports First Quarter Fiscal 2024 Financial Results Total revenue of $14.5 million and diluted earnings per share (EPS) of $0.10 Maintains full-year revenue guidance of $66 to $69 million (+10-15%) and EPS guidance of $0.66 to $0.68 LANCASTER, CA, January 3, 2024 – Simulations Plus, Inc. (NASDAQ: SLP) (“Simulations Plus”), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today reported financial results for its first quarter fiscal 2024, ended November 30, 2023. First Quarter Financial Highlights • Total revenue increased 21% to $14.5 million • Software revenue increased 25% to $7.6 million, representing 52% of total revenue • Services revenue increased 17% to $6.9 million, representing 48% of total revenue • Gross profit increased 6% to $9.8 million; gross margin was 68% • Adjusted EBITDA of $3.4 million, representing 23% of total revenue • Net income of $1.9 million and diluted earnings per share (EPS) of $0.”
Will Frederick was appointed as Chief Operating Officer at Simulations Plus, Inc..
“Will Frederick, the Company’s Chief Financial Officer, was appointed to the additional role of Chief Operating Officer.”
Earnings Releases
Simulations Plus, Inc. updated its fourth quarter and fiscal year ended August 31, 2023 guidance (initiated).
“On October 25, 2023, Simulations Plus, Inc., a California corporation (the “Company”), issued a press release announcing financial results for its fourth quarter and fiscal year ended August 31, 2023.”
Earnings Releases
Simulations Plus, Inc. reported Third quarter of fiscal 2023 ended May 31, 2023 results: revenue $16.2 million, net income $4.0 million, EPS $0.20. Guidance reaffirmed.
“Simulations Plus Reports Third Quarter Fiscal 2023 Financial Results Total revenue of $16.2 million and diluted earnings per share (EPS) of $0.20 Maintains full-year revenue guidance of $59.3 - $62.0 million (+10-15%) and EPS guidance of $0.63 - $0.67”
Material Agreements
Simulations Plus, Inc. entered into Earnout Agreement with the Company, Merger Sub, Immunetrics and the Stockholder Representative valued at up to $8.0 million of Earnout Payments (effective 2023-06-16).
“Pursuant to the Earnout Agreement, the Company shall pay the Equityholders an aggregate amount of up to $8.0 million of Earnout Payments”
Material Agreements
Simulations Plus, Inc. entered into Agreement and Plan of Merger with Immunetrics, Inc. and LaunchCyte LLC, as representative of the stockholders of Immunetrics valued at $13,705,082.50 (effective 2023-06-16).
“On June 16, 2023, Simulations Plus, Inc. (the “Company”) entered into an Agreement and Plan of Merger (the “Merger Agreement”) by and among the Company, Insight Merger Sub, Inc., a wholly-owned subsidiary of the Company (“Merger Sub”), Immunetrics, Inc. (“Immunetrics”), a company specializing in quantitative systems pharmacology modeling, and LaunchCyte LLC, as representative of the stockholders of Immunetrics (the “Stockholder Representative”).”
Steven Chang was appointed as President at Simulations Plus, Inc..
“Steven Chang, the Chief Executive Officer of Immunetrics pre-Merger, was appointed as President of the Surviving Corporation”
Earnings Releases
Simulations Plus, Inc. reported second quarter of fiscal 2023 ended February 28, 2023 results: revenue $15.8 million, net income $4.2 million, EPS $0.20. Guidance reaffirmed.
“Simulations Plus Reports Second Quarter Fiscal 2023 Financial Results Total revenue of $15.8 million; Diluted Earnings Per Share (EPS) of $0.20; Maintains full-year revenue guidance of $59.3 - $62.0 million (+10-15%) and EPS Guidance of $0.63 - $0.67”
Shareholder Votes
Simulations Plus, Inc. shareholders approved Advisory (non-binding) vote on named executive officer compensation at the 2023-02-09 meeting.
“To approve on an advisory, nonbinding basis, name executive officer compensation. This proposal was approved based upon the following votes: Votes For Votes Against Votes Abstaining 12,638,735 640,930 29,990”
Shareholder Votes
Simulations Plus, Inc. shareholders approved Approval of an amendment to the 2021 Equity Incentive Plan to increase authorized shares from 1,300,000 to 1,550,000 at the 2023-02-09 meeting.
“To approve an amendment to the 2021 Plan to increase the number of shares authorized for issuance thereunder from 1,300,000 shares to 1,550,000 shares of common stock of the Company. This proposal was approved based upon the following votes: Votes For Votes Against Votes Abstaining 12,453,721 831,073 24,861”
Shareholder Votes
Simulations Plus, Inc. shareholders approved Ratification of the selection of Rose, Snyder & Jacobs LLP as the independent registered public accounting firm at the 2023-02-09 meeting.
“To ratify the selection of Rose, Snyder & Jacobs LLP as the independent registered public accounting firm for the Company for the fiscal year ending August 31, 2023. This proposal was approved based upon the following votes: Votes For Votes Against Votes Abstaining 14,559,325 33,568 16,439”
Shareholder Votes
Simulations Plus, Inc. shareholders approved Election of five directors to serve on the Board until the next Annual Meeting at the 2023-02-09 meeting.
“Nominees Votes For Votes Withheld Broker Non-votes Walter Woltosz 13,179,230 130,425 1,299,677 Dr. John K. Paglia 13,235,676 73,979 1,299,677 Sharlene Evans 13,226,141 83,514 1,299,677 Dr. Daniel Weiner 13,234,805 74,850 1,299,677 Lisa LaVange 13,228,618 81,037 1,299,677”
Material Agreements
Simulations Plus, Inc. entered into accelerated share repurchase agreement with Morgan Stanley & Co. LLC valued at $20 million (effective 2023-01-11).
“On January 11, 2023, Simulations Plus, Inc., a California corporation (the “Company”), entered into an accelerated share repurchase agreement (the “ASR Agreement”) with Morgan Stanley & Co. LLC (“Morgan Stanley”) to repurchase an aggregate of $20 million of the Company’s outstanding common shares.”
Earnings Releases
Simulations Plus, Inc. reported first quarter of fiscal 2023, ended November 30, 2022 results: revenue $12.0 million, net income $1.2 million, EPS $0.06. Guidance reaffirmed.
“First Quarter Financial Highlights (Fiscal 2023 vs. Fiscal 2022): • Total revenue decreased 4% to $12.0 million; • Software revenue decreased 17% to $6.1 million, representing 51% of total revenue; • Services revenue increased 17% to $5.9 million, representing 49% of total revenue; • Gross profit decreased 4% to $9.3 million; gross margin was 78%; • Net income of $1.2 million and diluted EPS of $0.06, compared to net income of $3.0 million and diluted EPS of $0.15; • Adjusted EBITDA of $3.0 million, representing 25% of total revenue.”
Daniel Weiner was appointed as lead independent director at Simulations Plus, Inc..
“Additionally, upon recommendation of the Nominating & Corporate Governance Committee, the Board appointed Daniel Weiner as the lead independent director of the Board.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.